Aclaris Therapeutics
ACRS
$1.19
Share price
0.00%
Change (1 day)
-85.45%
Change (1 year)
Categories
Operating Margin for Aclaris Therapeutics (ACRS)
Operating Margin as of May 2024 (TTM): -312.32%
According to Aclaris Therapeutics's latest financial reports and stock price the company's current Operating Margin is -312.32%. At the end of 2021 the company had an Operating Margin of -1,343.96%.
Operating Margin history for Aclaris Therapeutics from 2018 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -1,343.96% | 69.7% |
| 2020 | -791.98% | -70.52% |
| 2019 | -2,686.11% | 104.2% |
| 2018 | -1,315.41% | -68.53% |
| 2017 | -4,180.21% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.